Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07329153 · ClinicalTrials.gov registry record · NA
Neuronavigated aiTBS for TRD
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 247
- Enrollment target
NCT07329153 is a NA study that has not yet begun recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 247 participants.
The verdict
NCT07329153, a NA study, has not yet begun recruiting, sponsored by University of Texas Southwestern Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm the efficacy of two recently introduced repetitive transcranial magnetic stimulation (rTMS) interventions - accelerated intermittent theta-burst stimulation (aiTBS) and individualized neuronavigation - in treatment-resistant depression (TRD). Using a three-arm design (neuronavigated aiTBS, non-neuronavigated aiTBS, and sham), this randomized controlled trial (RCT) is the first to specifically investigate the incremental benefit of neuronavigation within an accelerated stimulation protocol, as well as the first confirmatory RCT comparing the efficacy of each of these active treatments vs. sham, overcoming previous generalizability issues and being conducted in an independent, multicenter US TRD sample.
Interventions
- DEVICE aiTBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2026-07 |
| Est. Completion | 2031-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07329153
The ClinicalTrials.gov registry entry for NCT07329153 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which aiTBS is the first listed.
NCT07329153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07329153 about?
NCT07329153 is a clinical study titled "Neuronavigated aiTBS for TRD". The purpose of this study is to confirm the efficacy of two recently introduced repetitive transcranial magnetic stimulation (rTMS) interventions - accelerated intermittent theta-burst stimulation (aiTBS) and individualized neuronavigation - in treatment-resistant depression (TRD). Using a three-arm...
What is the current status of trial NCT07329153?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 247 participants. The study started on 2026-07. Estimated completion is 2031-09.
What interventions are being tested in trial NCT07329153?
The interventions under investigation include: aiTBS (DEVICE).
Who is sponsoring clinical trial NCT07329153?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.